Recombinant Anti-PDGFR1 x Anti-VEGF Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-PDGFR1 and anti-VEGF IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two antigens simultaneously. It is designed for the research of Neovascular ocular disorders; Cancers therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY